The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,761.00
Bid: 1,757.50
Ask: 1,758.00
Change: 27.50 (1.59%)
Spread: 0.50 (0.028%)
Open: 1,736.00
High: 1,767.00
Low: 1,736.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: FTSE 100 treads water at eight-month high

Tue, 21st Jan 2014 16:38

- FTSE 100 fails to break 2013 intraday high- Credit squeeze eases in China- IMF lifts global growth forecaststechMARK 2,846.40 -0.25%FTSE 100 6,834.26 -0.04%FTSE 250 16,144.20 -0.51%After a choppy session, UK markets finished broadly flat on Tuesday as the FTSE 100 teetered at levels not reached in eight months.An easing of credit conditions in China and upwards revisions to growth estimates by the International Monetary Fund (IMF) failed to keep the Footsie in positive territory today, as cautiousness set in after a 3.5% rise over the past month.Despite US markets reopening after a three-day weekend - Wall Street was closed for Martin Luther King Jr. Day yesterday - it was another lacklustre session in London with trading rangebound for most of the day. The benchmark FTSE 100 finished at 6,834.26, down just 2.47 points, erasing gains late on after coming close to last year's intraday high of 6,875 in afternoon trade. Yesterday, the index hit 6,836.72, its best closing level since reaching 6,840.27 in May 2013.Toby Morris, Senior Sales Trader at CMC Markets, said that the 6,875 intraday high reached last year is "the only historical resistance to break before taking on all-time high recorded back in 1999".Stocks rose initially this morning, tracking gains for Asian markets overnight on the back of an easing of credit conditions in China as the central bank injected fresh liquidity into the country's large banks to meet demand for cash ahead of Chinese New Year later this month.Meanwhile, the IMF lifted its growth forecast for the global economy to 3.7% for 2014, up from its previous estimate of 3.6%, owing to upwards revisions to forecasts in the UK, US, Europe and Japan.On a negative note, there was a surprise fall in the German ZEW index on economic sentiment which fell from 62 to 61.7 in January, worse than rise to 64 expected by analysts. The current situation index, however, jumped from 32.4 to 41.2.Intertek jumps on SGS readacross, Unilever gainsIntertek, a provider of testing and safety solutions, jumped as a result of readacross from its sector peer, Swiss firm SGS, which posted upbeat full-year results. Consumer products group Unilever was also high riser today after reporting underlying sales growth of 4.3% for 2013, helped by strong growth in the emerging markets.Drugs maker GlaxoSmithKline rose after reporting that its new HIV treatment, Tivicay, has received approval in Europe. Mining stocks sank on weak metal prices, pushing Randgold Resources, Anglo American, Rio Tinto, Fresnillo, BHP Billiton, and Glencore Xstrata all firmly lower. Investors were also focusing on comments from Goldman Sachs, which adjusted its commodity price forecasts for 2014 and beyond. William Hill and Ladbrokes slumped after JPMorgan Cazenove expressed concerns about potential regulatory restrictions on machine gaming, which could result in "material downgrades and significant shop closures" at the bookmakers. Weir Group slumped after fellow oil services provider Baker Hughes highlighted higher costs for the sector in its fourth-quarter results. Baker said a surplus of natural-gas supply led to lower prices and pushed energy companies to shift operations to oil-rich shale, which is more difficult to tap. British Land was named as HSBC's key 'overweight'-rated company, giving the stock a lift today, as the bank gave an upbeat outlook for UK property sector.FTSE 100 - RisersAssociated British Foods (ABF) 2,806.00p +4.23%Intertek Group (ITRK) 3,000.00p +3.16%Hargreaves Lansdown (HL.) 1,549.00p +2.65%Imperial Tobacco Group (IMT) 2,284.00p +2.51%Standard Chartered (STAN) 1,358.00p +2.26%easyJet (EZJ) 1,710.00p +2.21%Coca-Cola HBC AG (CDI) (CCH) 1,768.00p +2.20%Diageo (DGE) 1,985.00p +1.95%Unilever (ULVR) 2,480.00p +1.76%Babcock International Group (BAB) 1,426.00p +1.71%FTSE 100 - FallersRio Tinto (RIO) 3,231.50p -3.13%Antofagasta (ANTO) 819.50p -3.02%Anglo American (AAL) 1,356.00p -2.66%Weir Group (WEIR) 2,174.00p -2.38%Aberdeen Asset Management (ADN) 426.00p -2.16%Morrison (Wm) Supermarkets (MRW) 250.10p -1.88%William Hill (WMH) 355.40p -1.82%Randgold Resources Ltd. (RRS) 4,112.00p -1.74%BHP Billiton (BLT) 1,854.50p -1.70%BAE Systems (BA.) 437.50p -1.49%FTSE 250 - RisersRank Group (RNK) 150.00p +3.88%African Barrick Gold (ABG) 206.50p +2.94%Homeserve (HSV) 304.30p +2.15%Petra Diamonds Ltd.(DI) (PDL) 125.00p +2.04%Ocado Group (OCDO) 527.00p +2.03%Xaar (XAR) 1,031.00p +1.98%Greencore Group (GNC) 242.70p +1.85%Grainger (GRI) 221.70p +1.70%JD Sports Fashion (JD.) 1,651.00p +1.60%Daejan Holdings (DJAN) 4,845.00p +1.57%FTSE 250 - FallersKazakhmys (KAZ) 185.50p -4.87%Ladbrokes (LAD) 158.60p -4.86%Ferrexpo (FXPO) 171.40p -4.78%Imagination Technologies Group (IMG) 199.80p -4.36%Kenmare Resources (KMR) 18.21p -3.65%Bodycote (BOY) 685.00p -3.52%Thomas Cook Group (TCG) 180.10p -3.28%Vedanta Resources (VED) 908.50p -3.04%Laird (LRD) 306.60p -2.97%Ophir Energy (OPHR) 299.40p -2.95%BC
More News
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.